熱門資訊> 正文

Acurx Pharmaceuticals提交5000万美元混合货架产品

2025-07-10 05:45

纳比特(NA) 0
盛大科技(SDA) 0
Acurx Pharmaceuticals LLC Ordinary Shares(ACXP) 0

Acurx Pharmaceuticals (NASDAQ:ACXP) has filed a shelf registration to offer up to $50M in securities over time.
The offering may include common stock, preferred stock, debt securities, warrants, rights, or units, in any combination.
Securities may also be issued through conversion or exercise of other securities (e.g., preferred to common, debt to equity, or warrants to stock).
Source: SEC filing

More on Acurx Pharmaceuticals

Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript
Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment
Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
Historical earnings data for Acurx Pharmaceuticals
Financial information for Acurx Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。